BAXBaxter International Inc.
$22.61
$0.74
(3.17%)
Closed $22.61
$0.04
(0.18%)
After Hours
EarningsJul 30
Mkt Cap$12.06B
Vol6.55M
Baxter to Host Second-Quarter 2026 Financial Results Conference Call for Investors
Baxter International Inc. (NYSE:BAX), a leading global medtech company, will host a conference call to discuss its second-quarter 2026 financial results on Thursday, July 30, 2026, at 7:30 a.m. Central Time. To participate in this conference call please follow this link...
Business Wire
WST Stock Up Nearly 33% YTD: Will the Uptrend Continue in the Rest of 2026?
WST has surged nearly 33% YTD as strong earnings, GLP-1 demand and biologics growth fuel momentum that could extend through 2026.
Zacks
CRMD's Growth Story Expands Beyond DefenCath Into New Trends
CorMedix broadens beyond DefenCath with Melinta assets, Rezzayo potential and cost synergies as reimbursement changes test long-term earnings durability.
Zacks
Baxter Publishes 2025 Sustainability Report Highlighting Refreshed Strategy, Ongoing Commitment to Drive Meaningful Impact
Baxter International Inc. (NYSE:BAX), a global medtech leader, today published its newly renamed 2025 Sustainability Report, highlighting the companys progress and refreshed approach to advancing a sustainable and responsible business model. This press release features multimedia. View the full...
Business Wire
Baxter's Unit Synovis MCA to Lead Global Rollout of the SHIYA Platform
BAX gains as Synovis MCA signs a multi-year deal to commercialize MediThinQ's SHIYA 3D surgical visualization platform worldwide.
Zacks
MediThinQ and Synovis Micro Companies Alliance, Inc. Announce Strategic Global Distribution Agreement to Redefine Microsurgery with the SHIYA 3D Visualization Platform
MediThinQ and Synovis Micro Companies Alliance, Inc. Announce Strategic Global Distribution Agreement to Redefine Microsurgery with the SHIYA 3D Visualization Platform MediThinQ and Synovis Micro Companies Alliance, Inc. Announce Strategic Global Distribution Agreement to Redefine Microsurgery with...
PR Newswire
Reasons to Retain Baxter International Stock in Your Portfolio for Now
BAX is pursuing a broad turnaround as innovation, resilient demand, and AI integration support recovery despite regulatory risks and margin pressure.
Zacks
DaVita Stock Gains From Integrated Kidney Care and CKCC Progress
DVA expands its IKC platform, tops CKCC savings in first-quarter 2026 and rolls out AI ScheduleHub to boost scheduling and staffing.
Zacks
BAX Crosses Above Key Moving Average Level
In trading on Tuesday, shares of Baxter International Inc (Symbol: BAX) crossed above their 200 day moving average of $19.85, changing hands as high as $20.16 per share. Baxter International Inc shares are currently trading up about 4.1% on the day. The chart below shows the o...
Nasdaq News: Markets
FMS and Home Dialysis: How 5008X Could Reset Demand
FMS scales 5008X high-volume HDF and expands home dialysis, aiming for benefits later in 2026 and a bigger payoff in 2027+.
Zacks
<
1
2
...
>
Advertisement|Remove ads.
SPY20
43
SG2
1
NFLX20
30Advertisement|Remove ads.